Regenxbio RGNX WA — Operating Lease Liability
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Regenxbio’s 10-K, filed March 5, 2026.
- Filed
- Mar 5, 2026, 4:21 PM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-094013
In October 2022, the Company entered into an operating lease for office space in Washington, D.C. (the DC Lease). The lease term commenced in October 2022 and expires in October 2027. The Company has an option to extend the term of the lease for five additional years. As of December 31, 2025, the Company’s extension option under the DC Lease was excluded from the measurement of the right-of-use assets and lease liabilities as it was not reasonably certain of exercise. As of December 31, 2025 the Company had recorded right-of-use assets of $2.7 million and lease liabilities of $2.8 million related to the DC Lease.
ITEM 16. FORM 10-K SUMMARY
FAQ
- What is Regenxbio's WA — operating lease liability?
- Regenxbio (RGNX) reported WA — operating lease liability of $2.8M in Q4 2025.
- What does WA — operating lease liability mean?
- This metric represents the present value of future lease payments for assets utilized by the WA segment, recognized as a financial obligation. It reflects the company's contractual commitment to make payments for the right to use leased property, plant, or equipment over the remaining lease term. Analyzing this liability provides insight into the segment's fixed cost structure and the long-term financial obligations associated with its operational infrastructure.
Ask your AI about Regenxbio's wa — operating lease liability.
Connect your AI assistant and compare it to peers, right in your chat.
